The Role of Interleukin 2 in the Development of Autoimmune Thyroiditis

References

• Smith K. A. Interleukin 2: inception, impact, and implications. Science 1988; 240: 1169–1176
   PubMed Web of Science ®Google Scholar
• Waldman T. A. The Interleukin-2 receptor. J. Biol. Chem 1991; 266: 2681–2684
   Google Scholar
• Kroemer G., Toribio M. L., Martínez-A C. Interleukin 2: counteracting pleiotropism by compartmentalization. New Biologist 1991; 3: 219–229
   Google Scholar
• Malkovsky M., Medawar P. B., Thatcher D. R., Toy J., Hunt R., Rayfield L. S., Doré C. Acquired immunological tolerance of foreign cells is impaired by recombinant interleukin 2 or vitamin A acetate. Proc. Natl. Acad. Sci. USA 1985; 82: 536–538
   PubMed Web of Science ®Google Scholar
• Kroemer G., Andreu-Sánchex J. L., Gonzalo J. A., Gutierrez-Ramos J. C., Martínez-A C. Interleukin-2, autotolerance, and autoimmunity. Adv. Immunol 1991; 150: 147–235
   Google Scholar
• Huang C. M., Elin R. J., Ruddel M., Silva C., Lotze M. T., Rosenberg S. A. Changes in laboratory results for cancer patients treated with interleukin-2. Clin. Chem 1990; 36: 431–434
   Google Scholar
• Kroemer G., Schauenstein K., Wick G. Is autoimmunity a side effect of interleukin 2 production?. Immunol. Today 1986; 7: 199–200
   Google Scholar
• Kroemer G., Wick G. The role of interleukin 2 in autoimmunity. Immunol. Today 1989; 10: 246–251
   PubMedGoogle Scholar
• Smith J. B., Talal N. Significance of self-recognition and IL-2 for immunoregulation, autoimmunity and cancer. Scand. J. Immunol 1982; 16: 269–278
   PubMed Web of Science ®Google Scholar
• Huang Y. -P., Perrin L. H., Miescher P. A., Zubler R. H. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J. Immunol 1988; 141: 827–833
   PubMed Web of Science ®Google Scholar
• Trotter J. L., Clifford D. B., Anderson C. B., van der Veen R. C., Hicks B. C., Banks G. Elevated serum interleukin-2 levels in chronic progressive multiple sclerosis. New Engl. J. Med 1988; 318: 1206
   PubMedGoogle Scholar
• Atkins M. B., Mier J. W., Parkinson D. R., Gould J. A., Berkman E. M., Kaplan M. M. Hypothyroidism after treatment with interleukin 2 and lymphokine-activated killer cells. New Engl. J. Med 1988; 318: 1557–1563
   PubMed Web of Science ®Google Scholar
• Kyle V., Coughlan R. J., Tighe H., Waldmann H., Hazleman B. J. Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis. Ann. Rheumatic Dis 1989; 48: 428–429
   PubMed Web of Science ®Google Scholar
• Kroemer G., de Cid R., Moreno de Alboran N., Gonzalo J. -A., Iglesias A., Martinez C., Gutierrez-Ramos J. C. Immunological self tolerance: an analysis employing cytokines or cytokine receptors encoded by transgenes or by a recombinant vaccinia virus. Immunol. Rev 1991; 122: 183–204
   Google Scholar
• de Cid R., Kroemer G., Moreno de Alboran I., Martínez-A C. Effect of IL-2 on CD8 expression on self-specific T cells in mice bearing a male-specific transgenic T cells receptor. 1992, Submitted
   Google Scholar
• Andreu-Sánchez J. L., Moreno de Alborán I., Marcos M. A. R., Sánchez-Movilla A., Martínez-A C., Kroemer G. IL-2 abrogates the non-responsive state of T cells expressing a forbidden TCR repertoire and induces autoimmune disease in neonatally thymectomized mice. Exp. J. Med 1991; 173: 1323–1329
   PubMedGoogle Scholar
• Gutierrez-Ramos G., Moreno de Alboran I., Martinez-A C. In vivo interleukin 2 administration turns on anergic autoreactive T cells and provokes autoimmune disease. Eur. J. Immunol, in press
   Google Scholar
• Wick G., Moest J., Schauenstein K., Kroemer G., Dietrich H., Ziemiecki A., Faessler R., Schwarz S., Neu N., Hala K. Spontaneous autoimmune thyroiditis-a bird's eye view. Immmunol. Today 1985; 6: 359–364
   Google Scholar
• Kroemer G., Faessler R., Wick G. Disturbed immune regulation in spontaneous autoimmune thyroiditis. Concepts lmmunopathol 1988; 5: 106–129
   Google Scholar
• Wick G., Hala K., Brezinschek H. -P., Dietrich H., Wolf H., Kroemer G. The Obese strain (OS) of chickens: an animal model for spontaneous autoimmune thyroiditis. Adv. Immunol 1989; 47: 433–500
   PubMed Web of Science ®Google Scholar
• Kroemer G., Gastinel L. N., Neu N., Auffray C., Wick G. How many genes code for organ-specific autoimmunity?. Autoimmunity 1990; 6: 215–233
   Web of Science ®Google Scholar
• Schauenstein K., Kroemer G. Avian Iymphokines. Avian Immunology: Basis and Practice, P Toivanen, P. Toivanen. CRC Press, New York 1987; Vol. 1: 213–227
   Google Scholar
• Hala K., Schauenstein K., Neu N., Kroemer G., Wolf H., Boeck G., Wick G. A monoclonal antibody reacting with a membrane determinant expressed on activated chicken T lymphocytes. Eur. J. Immunol 1986; 16: 1331–1336
   PubMed Web of Science ®Google Scholar
• Fedecka-Bruner B., Penninger J., Vaigot R., Lehmann A., Martinez-A C., Kroemer G. Developmental expression of IL-2 receptor light chain (CD25) in the chicken embryo. Dev. Immunol 1991; 1: 237–242
   Google Scholar
• Kroemer G., Martínez-A C. Invariant involvement of interleukin 2 in thymocyte differentiation. Immunol. Today 1991; 12: 246
   Google Scholar
• Schauenstein K., Kroemer G., Hala K., Boeck G., Wick G. Chicken-activated-T-lymphocyticantigen (CATLA) recognized by monoclonal antibody INN-CH 16 represents the IL-2 receptor. Dev. Comp. Immunol 1988; 12: 823–831
   Google Scholar
• Kroemer H., Sundick R. S., Schauenstein K., Hala K., Wick G. Analysis of lymphocytes infiltrating the thyroid gland of Obese strain chickens. J. Immunol 1985; 135: 2452–2457
   Google Scholar
• Champion B. R., Page K. R., Parish N., Rayner D. C., Dawe K., Biswas-Hughes G., Cooke A., Geysen M., Roitt I. M. Identification of a thyroxine-containing self-epitope of thyroglobulin which triggers thyroid autoreactive T cells. J. Exp. Med 1991; 174: 363–370
   PubMed Web of Science ®Google Scholar
• Cohen S. B., Diamantstein T., Weetman A. P. The effect of T cell subset depletion on autoimmune thyroiditis in the Buffalo strain. Immunol. Lett 1989; 23: 263–267
   Google Scholar
• Kroemer G., Neu N., Faessler R., Kuehr T., Dietrich H., Hala K., Wick G. Immunogenetic analysis of spontaneous autoimmune thyroiditis of Obese strain (OS) chickens with spontaneous autoimmune thyroiditis. Clin. Immunol. Immunopathol 1989; 52: 202–213
   Google Scholar
• Kroemer G., Schauenstein K., Neu N., Strieker K., Wick G. In vitro T cell hyperreactivity in Obese strain (OS) chickens is due to a defect in nonspecific suppressor mechanism(s). J. Immunol 1985; 135: 2458–2463
   Google Scholar
• Schauenstein K., Kroemer G., Sundick R. S., Wick G. Enhanced response to ConA and production of TCGF by lymphocytes of Obese strain (OS) chickens with spontaneous autoimmune thyroiditis. J. Immunol 1985; 134: 872–879
   PubMed Web of Science ®Google Scholar
• Schauenstein K., Kroemer G., Strieker K., Hála K., Wick G. T cell hyperreactivity in Obese strain (OS) chickens. Different mechanisms operative in spleen and peripheral blood lymphocyte activation. Immunobiol 1987; 175: 226–235
   Google Scholar
• Kroemer G., Schauenstein K., Dietrich H., Faessler R., Wick G. Mechanisms of T cell hyperreactivity in Obese strain (OS) chickens with spontaneous autoimmune thyroiditis. Lack in non-specific suppression is due to a primary adherent cell defect. J. Immunol 1987; 138: 2104–2110
   PubMed Web of Science ®Google Scholar
• Kroemer G., Faessler R., Hala K., Boeck G., Schauenstein K., Brezinschek H. -P., Neu N., Dietrich H., Jakobcr R., Wick G. Genetic analysis of extrathyroidal features of Obese strain (OS) chickens with spontaneous autoimmune thyroiditis. Eur. J. Immunol 1988; 18: 1499–1505
   Google Scholar
• Eastcott J. W., Schwartz R. S., Datta S. K. Genetic analysis of the inheritance of B cell hyperreactivity in relation to the development of autoantibodies and glomerulonephritis in NZB × SWR crosses. J. Immunol 1983; 131: 2232–2239
   PubMed Web of Science ®Google Scholar
• Grubeck-Loebenstein B., Buchan G., Chantry D., Kassal H., Londei M., Pirich K., Barrett K., Tunre M., Waldhausl W., Feldmann M. Analysis of intrathyroidal cytokine production in thyroid epithelial disease: thyroid follicular cells produce interleukin-1a and interleukin-6. Clin. Exp. Pathol 1989; 77: 324–330
   Google Scholar
• Feldmann M., Brennan M., Chantry D., Haworth C., Turner M., Katsikis E., Londei M., Abney E., Buchan G., Barrett K., Corcoran A., Kissonerghis M., Zheng R., Grubeck-Loebenstein B., Barkley D., Chu C. Q. M. F., Maini R. N. Cytokine assays: role in evaluation of the pathogenesis of autoimmunity. Immunol. Rev 1991; 119: 105–123
   PubMed Web of Science ®Google Scholar
• Rutenfranz I., Kruse A., Rink L., Wenzel B., Arnholdt H., Kirchner H. In situ hybridization of the mRNA for interferon-γ, interferon α interferon-β, interleukin-1b and interleukin-6 and characterization of infiltrating cells in thyroid tissues. Scand. J. Immunol, in press
   Google Scholar
• Grubeck-Loebenstein B., Turner M., Pirich K., Kassal H., Londei M., Waldhaeusl W., Feldmann M. CD4+ T-cell clones from autoimmune thyroid tissue cannot be classified according to their lymphokine production. Scand. J. Immunol 1990; 32: 433–440
   PubMed Web of Science ®Google Scholar
• Turner M., Londei M., Feldmann M. Human T cells from autoimmune and normal individual can produce tumor necrosis factor. Eur. J. Immunol 1987; 17: 1807–1814
   PubMed Web of Science ®Google Scholar
• del Prete G. F., Tiri A., Mariotti S., Pinchera A., Ricci M., Romagnani S. Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis. Clin. Exp. Immunol 1987; 69: 323–331
   PubMed Web of Science ®Google Scholar
• Bagnasco M., Ferrini S., Venuti D., Prigione I., Torre G., Biassoni R., Canonica G. W. Clonal analysis of T lymphocytes infiltrating the thyroid gland in Hashimoto's thyroiditis. Int. Arch. Allergy Appl. Immunol 1987; 82: 141–146
   PubMedGoogle Scholar
• Bagnasco M., Venuti D., Prigione I., Torre G. C., Ferrini S., Canonica G. W. Graves' disease: phenotypic and functional analysis at the clonal level of the T-cell repertoire in peripheral blood and in thyoid. Clin. Immunol. Immunopathol 1988; 47: 230–239
   PubMedGoogle Scholar
• del Prete G. F., Vercelli D., Tiri A., Maggi E., Mariotti S., Pinchera A., Ricci M., Romagnani S. In vivo activated cytotoxic T cells in the thyroid infiltrate of patients with Hashimoto's thyroiditis. Clin. Exp. Immunol 1986; 65: 140–147
   PubMed Web of Science ®Google Scholar
• Maron R., Zerubavel R., Friedman A., Cohen I. R. T lymphocyte line specific for thyroglobulin produces or vaccinates against autoimmune thyroiditis in mice. J. Immunol 1983; 131: 2316–2322
   PubMed Web of Science ®Google Scholar
• Rémy J. J., Salamero J., Michel-Bechet M., Charreire J. Experimental autoimmune thyroiditis induced by recombinant interferon-γ. Immunol. Today 1987; 8: 73–75
   PubMedGoogle Scholar
• McCoombs C. C., Michalski J. R., deShazo R. D., Bozelka B., Lane J. T. L. Immune abnormalities associated with HLA-B8: lymphocyte subsets and functional correlates. Clin. Immunol. Immunopathol 1986; 39: 283–293
   Google Scholar
• Hashimoto S., McCoombs C. C., Michalski J. P Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3 in clinically healthy individuals. Clin. Exp. Immunol 1989; 75: 317–326
   Google Scholar
• Modica M. A., diLorenzo G., Galluzzo A., Giordano C., Portelli M. R., Candore G., Caruso C. Soluble interleukin-2 receptor secretion defect in vitro in HLA-B8, DR3 positive subjects. Autoimmun 1990; 7: 87–96
   PubMed Web of Science ®Google Scholar
• Modica M. A., Zambito A. M., Candore G., Caruso C. Markers of T lymphocyte activation in HLA-B8,DR3 positive individuals. Immunobiol 1990; 181: 257–266
   PubMedGoogle Scholar
• Gruschwitz M., Kroemer G., Moormann S., Faessler R., Dietrich H., Boeck G., Gershwin M. E., Abplanalp H., Boyd R., Wick G. Phenotypic and functional analysis of peripheral T lymphocytes in avian scleroderma. J. Autoimm 1991; 4: 577–593
   Google Scholar
• Eisenstein Z., Engelsman E., Weiss M., Kalechman Y., Sredni B. Production of and response to interleukin-2 in Graves' disease. J. Clin. Immunol 1988; 8: 349–355
   Google Scholar
• Hirooka -Y., Ohtake K., Nogimori T., Mitsuma T. Impaired production of interleukin-2 (IL2) in patients with Graves' disease by newly developed IL2 radioimmunoassay. Exp. Clin. Endocrinol 1990; 96: 64–72
   Google Scholar
• Matsubayashi S., Akasu E., Kasuga Y., Snow K., Keystone E., Volpé R. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis. Clin. Exp. Immunol 1990; 82: 63–68
   PubMedGoogle Scholar
• Lai K. N., Leung J. C., Chow C. C., Cockram C. S. T lymphocyte activation in euthyroid Graves' disease ophtalmopathy: soluble interleukin 2 receptor release, cellular interleukin 2 receptor expression and interleukin 2 production. Acta Endocrinol 1989; 120: 602–609
   Google Scholar
• Papic M., Srein-Streilein J., Zakarija M., McKenzie J. M., Guffee J., Fletcher M. A. Suppression of peripheral blood natural killer cell activity by excess thyroid hormone. J. Clin. Invest 1987; 79: 404–408
   Google Scholar
• Aiello A., Cristofaro M., Carrozza E., Verdone E., Carile L. Studio delle sottopopolazioni linfocitarie e del recettore solubile dell'interleuchina-2 nella tiroidite di Hashimoto e nella tiroidite subacuta. Clin. Ter 1990; 1990: 401–404
   Google Scholar
• Rosenberg S. A., Lotze M. T., Muul L. M., Chang A. E., Avis F. P., Leitman S., Linehan W. M., Robertson G. N., Lee R. E., Rubin J. T., Seipp C. A., Simpson C. G., White D. E. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. N. Engl. J. Med 1987; 316: 889–897
   PubMed Web of Science ®Google Scholar
• Kragel A. H., Travis W. D., Feinberg L., Pittaluga S., Striker L. M., Roberts W. C., Lotze M. T., Yang J. J., Rosenberg S. A. Pathologic findings associated with interleukin-2-bases immunotherapy for cancer: a postmortem study of 19 patients. Hum. Pathol 1990; 21: 493–502
   Google Scholar
• van Liessum P A., de Mulder P. H. M., Mattijssen E. J. M., Corstens F. H. M., Wagener D. J. T. Hypothyroidism and goitre during interleukin-2 therapy without LAK cells. Lancet 1989; i: 224
   Google Scholar
• Hartmann L. C., Urba W. J., Steis R. G., Smith J. W., II, vanderMolen L., Creekmore S. R., Longo D. L. Hypothyroidism after interleukin-2 therapy. J. Clin. Oncol 1989; 7: 686–687
   Google Scholar
• Beuzeboc R., Escourolle H., Dorval T., Dieras V., Mastorakos G., Luton J. R., Pouillard P. Hypothyroïdie après traitement par interleukine-2. La Presse Médicale 1989; 18: 727
   Google Scholar
• Mattijssen V. J. M., De Mulder P. H. M., Van Liessum P. A., Corstens F. H. M., Franks C. R., Wagener D. J. T. Hypothyroidism and goiter in a patient during treatment with interleukin-2. Cancer 1990; 65: 2686–2688
   Google Scholar
• Pirchert G., Jost L. M., Zöbeli L., Odermatt B., Pedio G., Stahel R. A. Thyroiditis after treatment with interleukin-2 and interferon α-2a. Br. J. Cancer 1990; 62: 100–104
   Google Scholar
• Berthaud R., Schlumberger M., Comoy E., Avril M. E., Le-Chevalier T., Spielmann M., Tursz T. Hypothyroidism and goiter during interleukin-2 therapy. J. Endocrinol. Invest 1990; 13: 689–690
   Google Scholar
• Atzpoden J., Körfer A., Franks C. R., Poliwoda H., Kirchner H. Home therapy with recombinant interleukin-2 and interferon-α2b in advanced human malignancies. Lancet 1990; i.: 1509–1512
   Google Scholar
• Kirchner H., Goldman U., Franks C. R., Poliwada H. Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experience. Ann. Biother 1990; 2: 145–154
   Google Scholar
• Burman R., Totterman T. H., Öberg K., Karlsson F. A. Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon. J. Clin. Endocrinol. Metab 1986; 63: 1086
   PubMed Web of Science ®Google Scholar
• Fentimann I. S., Balkwill F. R., Thomas B. S., Russell M. J., Todd I., Bottazzo G. F. An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer. Eur. J. Cancer Clin. Oncol 1988; 24: 1299
   Google Scholar
• Mattihssen V. I., deMulder P. H., vanLiessum P. A., Corstens F. H., Franks C. R., Wagener D. J. Hypothyroidism and goiter in a patient during treatment with interleukin 2. Cancer 1990; 65: 2686–2688
   Google Scholar
• Atkins M. B., Kaplan M. M., Demchak P. A., Robert N. J., Reichlin S., Mier J. W. Thyroid dysfunction after high-dose interleukin-2 therapy: an update. Autoimmune Thyroiditis, W. A. Scherbaum, U. Bogner, B. Weinheimer, G. F. Bottazzo. Springer Verlag, Berlin 1991; 271–281
   Google Scholar
• Kasuga Y., Matsubayashi S., Sakatsume Y., Miller N., Jamieson C., Volpé R. Effects of recombinant human interferon gamma on human thyroid tissues from patients with Graves' disease and normal subjects transplanted into nude mice. J. Endocrinol. Invest 1990; 13: 871–878
   PubMedGoogle Scholar
• Migita K., Eguchi K., Tezuka H., Otsubo S., Kawakami A., Nakao H., Ueki Y., Shimomura C., Matsunaga M., Ishikawa N., Ito K., Nagataki S. Cytotoxic activity of interleukin-2 (IL-2) activated killer cells toward thyroid epithelial cells. Clin. Exp. Immunol 1989; 77: 196–201
   Google Scholar
• Guerin V., Todd I., Hammond L. J., Bottazzo G. F. Suppression of HLA class II expression on thymocytes by interferon-alpha 1. Clin. Exp. Immunol 1990; 79: 341–345
   PubMed Web of Science ®Google Scholar
• Todd I., Pujol-Borrell R., Hammond L., Bottazzo G. F. Interferon-gamma induces HLA-DR expression by thyroid epithelium. Clin. Exp. Immunol 1985; 61: 265–272
   PubMed Web of Science ®Google Scholar
• Heslop H. E., Gottlieb D. J., Bianchi A. C. M., Meager A., Prentice H. G., Mehta A. B., Hoffbrand A. V., Brenner M. K. In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation. Blood 1989; 74: 1374–1380
   PubMed Web of Science ®Google Scholar
• Kasid A., Director E. P., Rosenberg S. A. Induction of endogenous cytokine-mRNA in circulating peripheral blood mononuclear cells by IL-2 administration to cancer patients. J. Immunol 1989; 143: 736–739
   PubMed Web of Science ®Google Scholar
• Buscema P., Todd I., Deuss U. Influence of tumor necrosis factor-alpha on the modulation of HLA class II molecules in human thyroid cells and its effect in interferon-gamma binding. J. Clin. Endocrinol. Metab 1989; 69: 433–438
   PubMed Web of Science ®Google Scholar
• Taverne J., Rayner D. C., Van der Meide P. H., Lydyard P. M., Cooke A. Cytotoxicity of tumor necrosis factor for thyroid epithelial cell and its regulation by interferon-γ. Eur. J. Immunol 1987; 17: 1855–1858
   Google Scholar
• Hoekman K., von Blomberg-van der Flier B. M. E., Wagstaff J., Drexhage H. A., Pinedo H. M. Reversible thyroid dysfunction during treatment with GM-CSE. Lancet 1991; 338: 541–542
   Google Scholar
• Hamilton E., Black M., Farquharson M. A., Stewart C., Foulis A. K. Spatial correlation between thyroid epithelial cells expressing class-II MHC molecules and interferon-gamma containing lymphocytes in human thyroid autoimmune disease. Clin. Exp. Immunol 1991; 83: 64–68
   PubMed Web of Science ®Google Scholar
• Londei M., Bottazzo G. F. Human T cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science 1985; 228: 85–89
   PubMed Web of Science ®Google Scholar
• Londei M., Lamb J. R., Bottazzo G. E., Feldmann M. Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature 1984; 312: 639–641
   PubMed Web of Science ®Google Scholar
• Frohman M., Francfort J. W., Cowing C. T-dependent destruction of thyroid isografts exposed to IFN-γ. J. Immunol 1991; 146: 2224–2234
   Google Scholar
• Kawakami Y., Kuzuya N., Watanabe T., Uchiyama Y., Yamashita K. Induction of experimental thyroiditis in mice by recombinant interferon 7 administration. Acta Endocrinol. (Copenh.) 1990; 122: 41–47
   PubMedGoogle Scholar
• Kung A. W., Jones B. M., Lai C. L. Effects of interferon-gamma therapy on thyroid function, T-lymphocyte subpopulations and induction of autoantibodies. J. Clin. Endocrinol. Metab 1990; 71: 1230–1234
   Google Scholar
• Wick G., Kroemer G., Neu N., Faessler R., Ziemiecki A., Ginzel M., Beladi I., Kuehr T., Hala K. The multifactorial pathogenesis of autoimmune disease. Immunol. Letters 1987; 161: 249–258
   Google Scholar
• Markmann J., Lo D., Naji R. D., Palmiter R. L., Brinster R. L., Heber-Katz E. Antigen presenting function of class II MHC expressing pancreatic beta cells. Nature 1988; 342: 476–478
   Google Scholar
• Lo D., Burkly L. C., Flavell R. A., Palmiter R. D., Brinster R. L. Tolerance in transgenic mice expressing class II major histocompatibility complex on pancreatic acinar cells. J. Exp. Med 1989; 170: 87–104
   PubMed Web of Science ®Google Scholar